Lupin Limited - Asset Resilience Ratio

Latest as of September 2025: 18.75%

Lupin Limited (LUPIN) has an Asset Resilience Ratio of 18.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Lupin Limited (LUPIN) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Rs62.82 Billion

≈ $679.38 Million USD Cash + Short-term Investments

Total Assets

Rs335.00 Billion

≈ $3.62 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Lupin Limited's Asset Resilience Ratio has changed over time. See LUPIN book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Lupin Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Lupin Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs30.40 Billion	9.08%
Short-term Investments	Rs32.42 Billion	9.68%
Total Liquid Assets	Rs62.82 Billion	18.75%

Asset Resilience Insights

Good Liquidity Position: Lupin Limited maintains a healthy 18.75% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Lupin Limited Industry Peers by Asset Resilience Ratio

Compare Lupin Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Lupin Limited (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Lupin Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	4.95%	Rs14.46 Billion ≈ $156.40 Million	Rs292.05 Billion ≈ $3.16 Billion	+0.82pp
2024-03-31	4.13%	Rs9.91 Billion ≈ $107.17 Million	Rs239.97 Billion ≈ $2.60 Billion	+1.19pp
2023-03-31	2.94%	Rs6.74 Billion ≈ $72.92 Million	Rs229.56 Billion ≈ $2.48 Billion	-1.71pp
2022-03-31	4.65%	Rs10.14 Billion ≈ $109.70 Million	Rs218.21 Billion ≈ $2.36 Billion	-5.77pp
2021-03-31	10.42%	Rs24.59 Billion ≈ $265.98 Million	Rs236.10 Billion ≈ $2.55 Billion	+0.64pp
2020-03-31	9.78%	Rs24.43 Billion ≈ $264.16 Million	Rs249.84 Billion ≈ $2.70 Billion	+2.08pp
2019-03-31	7.69%	Rs21.51 Billion ≈ $232.57 Million	Rs279.49 Billion ≈ $3.02 Billion	+6.50pp
2018-03-31	1.20%	Rs3.15 Billion ≈ $34.03 Million	Rs263.05 Billion ≈ $2.84 Billion	-6.92pp
2017-03-31	8.11%	Rs21.59 Billion ≈ $233.50 Million	Rs266.07 Billion ≈ $2.88 Billion	+8.06pp
2016-03-31	0.05%	Rs120.20 Million ≈ $1.30 Million	Rs226.25 Billion ≈ $2.45 Billion	-12.55pp
2015-03-31	12.60%	Rs16.56 Billion ≈ $179.08 Million	Rs131.38 Billion ≈ $1.42 Billion	+10.88pp
2014-03-31	1.73%	Rs1.76 Billion ≈ $19.08 Million	Rs102.06 Billion ≈ $1.10 Billion	+1.73pp
2012-03-31	0.00%	Rs1.50 Million ≈ $16.22K	Rs79.82 Billion ≈ $863.25 Million	--

pp = percentage points

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic

Market Cap

$11.39 Billion

Rs1.05 Trillion INR

Market Cap Rank

#2022 Global

#80 in India

Share Price

Rs2305.20

Change (1 day)

-0.27%

52-Week Range

Rs1851.80 - Rs2357.30

All Time High

Rs2396.10